Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells Via JNK/AP-1 Pathway

Overview

Journal Int J Gynecol Cancer

Specialties Gynecology & Obstetrics
Oncology

Date 2015 Jun 23

PMID 26098087

Citations 7

Authors

Qingqing Chen

Pan Chen

Xiaoyan Pang

Yanling Hu

Yi Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: Adrenomedullin (AM), a potent vasodilator peptide, presents in various kinds of tumors and promotes angiogenesis. We have previously reported that AM is expressed in epithelial ovarian carcinoma tissue. Here, we investigated the hypothesis that AM might regulate production of vascular endothelial growth factor (VEGF) in epithelial ovarian carcinoma and further promote angiogenic processes.

Methods: The messenger RNA expression of VEGF in human epithelial ovarian carcinoma cells (HO-8910) was examined by real-time polymerase chain reaction. Transcriptional control was analyzed by transient transfection assay of VEGF promoter-luciferase hybrid genes and chromatin immunoprecipitation assay. Activation of c-Jun N-terminal kinase (JNK) was detected by Western blotting. The formation of capillarylike structures by EA.hy926 cells cocultured with HO-8910 cells on Matrigel was also studied.

Results: We found that in HO-8910 cells, AM (10⁻¹⁰ to 10⁻⁷ mol/L) enhanced VEGF messenger RNA expression in a time- and concentration-dependent manner, as well as promoter activity. Furthermore, JNK was activated by AM stimulation. The AM-induced increase in VEGF expression was significantly attenuated by SP600125, a specific JNK inhibitor. Chromatin immunoprecipitation assay and promoter activity analysis showed that VEGF expression induced by AM required the activator protein 1 motif on the VEGF promoter. In an in vitro angiogenesis system for endothelial cells (EA.hy926) cocultured with HO-8910 cells, we observed that the addition of AM stimulated endothelial cell tube formation, which could be abolished by VEGF neutralizing antibody.

Conclusions: Our findings suggest that the JNK/Activator protein 1 pathway is involved in AM-induced VEGF expression in HO-8910 cells.

Citing Articles

Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions.

Xuan Z, Hu H, Xu J, Ling X, Zhang L, Li W J Cell Mol Med. 2025; 29(5):e70460.

PMID: 40074697 PMC: 11903196. DOI: 10.1111/jcmm.70460.

Deciphering tumour microenvironment and elucidating the origin of cancer cells in ovarian clear cell carcinoma.

Kamaraj U, Gautam P, Cheng T, Chin T, Tay S, Ho T bioRxiv. 2024; .

PMID: 39149248 PMC: 11326226. DOI: 10.1101/2024.08.06.606821.

Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.

Sanchez M, Rodriguez F, Covenas R Cancers (Basel). 2023; 15(6).

PMID: 36980580 PMC: 10046800. DOI: 10.3390/cancers15061694.

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Vazquez R, Riveiro M, Berenguer-Daize C, OKane A, Gormley J, Touzelet O Front Oncol. 2021; 10:589218.

PMID: 33489885 PMC: 7815935. DOI: 10.3389/fonc.2020.589218.

MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M Int J Oncol. 2019; 56(1):178-192.

PMID: 31789394 PMC: 6910186. DOI: 10.3892/ijo.2019.4928.

References

Pages G, Pouyssegur J . Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. Cardiovasc Res. 2005; 65(3):564-73. DOI: 10.1016/j.cardiores.2004.09.032. View

Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H . Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993; 192(2):553-60. DOI: 10.1006/bbrc.1993.1451. View

Li Y, Jiang C, Wang X, Zhang Y, Shibahara S, Takahashi K . Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides. 2007; 28(5):1129-43. DOI: 10.1016/j.peptides.2007.03.005. View

Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y . JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008; 314(3):421-9. DOI: 10.1016/j.yexcr.2007.10.002. View

Zhang Y, Zhang S, Shang H, Pang X, Zhao Y . Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway. Regul Pept. 2009; 157(1-3):44-50. DOI: 10.1016/j.regpep.2009.07.007. View

Baranello C, Mariani M, Andreoli M, Fanelli M, Martinelli E, Ferrandina G . Adrenomedullin in ovarian cancer: foe in vitro and friend in vivo?. PLoS One. 2012; 7(7):e40678. PMC: 3408475. DOI: 10.1371/journal.pone.0040678. View

Pang L, Zhang Y, Yu Y, Zhang S . Resistin promotes the expression of vascular endothelial growth factor in ovary carcinoma cells. Int J Mol Sci. 2013; 14(5):9751-66. PMC: 3676810. DOI: 10.3390/ijms14059751. View

Larrayoz I, Martinez-Herrero S, Garcia-Sanmartin J, Ochoa-Callejero L, Martinez A . Adrenomedullin and tumour microenvironment. J Transl Med. 2014; 12:339. PMC: 4272513. DOI: 10.1186/s12967-014-0339-2. View

Ichijo H . From receptors to stress-activated MAP kinases. Oncogene. 1999; 18(45):6087-93. DOI: 10.1038/sj.onc.1203129. View

10.

Ferrara N, Alitalo K . Clinical applications of angiogenic growth factors and their inhibitors. Nat Med. 1999; 5(12):1359-64. DOI: 10.1038/70928. View

11.

Rafii S . Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest. 2000; 105(1):17-9. PMC: 382591. DOI: 10.1172/JCI8774. View

12.

Carmeliet P . Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6(4):389-95. DOI: 10.1038/74651. View

13.

Asahara T, Kalka C, Isner J . Stem cell therapy and gene transfer for regeneration. Gene Ther. 2000; 7(6):451-7. DOI: 10.1038/sj.gt.3301142. View

14.

Carmeliet P, Jain R . Angiogenesis in cancer and other diseases. Nature. 2000; 407(6801):249-57. DOI: 10.1038/35025220. View

15.

Takahashi K . Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Tohoku J Exp Med. 2001; 193(2):79-114. DOI: 10.1620/tjem.193.79. View

16.

Bernatchez P, Rollin S, Soker S, Sirois M . Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. J Cell Biochem. 2002; 85(3):629-39. DOI: 10.1002/jcb.10155. View

17.

Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim H, Lu C . Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene. 2002; 21(50):7680-9. DOI: 10.1038/sj.onc.1205883. View

18.

Billottet C, Janji B, Thiery J, Jouanneau J . Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene. 2002; 21(53):8128-39. DOI: 10.1038/sj.onc.1205935. View

19.

Claffey K, Brown L, del Aguila L, Tognazzi K, Yeo K, Manseau E . Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 1996; 56(1):172-81. View

20.

Shima D, Gougos A, Miller J, Tolentino M, Robinson G, Adamis A . Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci. 1996; 37(7):1334-40. View